CUV — Clinuvel Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapHigh Flyer

Annual balance sheet for Clinuvel Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	66.7	82.7	122	157	184
Net Total Accounts Receivable
Net Total Receivables	6.61	16.1	16.2	22.2	26.2
Total Inventory
Prepaid Expenses
Total Current Assets	75.2	103	141	190	222
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.39	2.6	2.7	2.85	7.72
Net Goodwill
Other Long Term Assets
Total Assets	81.5	109	144	194	231
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.26	8.71	13.7	25.5	25.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	9.48	9.83	18.4	29.1	28.1
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	72.1	98.7	126	165	203
Total Liabilities & Shareholders' Equity	81.5	109	144	194	231
Total Common Shares Outstanding